MR spectroscopy moves from the brain to bones
Characterizing musculoskeletal tumors with MR spectroscopy could eliminate the need for standard imaging and histological staging. Researchers at Johns Hopkins University have found preliminary success using MRS at 3T to diagnose bone tumors.
Characterizing musculoskeletal tumors with MR spectroscopy could eliminate the need for standard imaging and histological staging. Researchers at Johns Hopkins University have found preliminary success using MRS at 3T to diagnose bone tumors.
Dr. Laura M. Fayad, an assistant professor of radiology, and colleagues examined six bone tumors. They correctly detected a choline peak in two malignant cases and no choline peak in four benign cases, Fayad told Diagnostic Imaging.
The group had previously been successful in using MRS at 1.5T to investigate resected tumors. Fayad reported that study at the 2004 RSNA meeting.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
